chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a pharmacist via call center representative and described the occurrence of numbness in fingers in a female patient who received SHINGRIX for prophylaxis. On 24th July 2018, the patient received SHINGRIX. In July 2018, less than a week after receiving SHINGRIX, the patient experienced numbness in fingers, pain in arm, shivers, bruising of hand and fever. On an unknown date, the outcome of the numbness in fingers, pain in arm, shivers, bruising of hand and fever were unknown. It was unknown if the reporter considered the numbness in fingers, pain in arm, shivers, bruising of hand and fever to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. The patient was vaccinated with SHINGRIX in the left deltoid. The patient experienced numbness of one finger on the left hand, small bruise on the palm of left hand and soreness of entire left arm.
Mild pain at injection site increased to moderate/moderately severe requiring two doses of acetaminophen 825 mg p.o.  Pain reached a maximum at around 9 pm on 1/4/21.  Malaise, body aches, skin sensitivity also increased during the day on 1/4, relieved somewhat by the Tylenol.  I was never able to document fever though I felt "feverish".   Awoke on 1/5/21 feeling better and all symptoms are steadily improving though not completely resolved at time of this report, 1045 hours on 1/5/21.
I was 22 months pregnant  I chose to get the vaccine because I work with Covid patients at hospital as a PA. 8 days after the vaccine, I got a needle stick at work. As part of the work up for this, they checked my ALT and it was markedly elevated (previously well within normal range).
Normal labor and delivery on 1/7/2022. Hospital admission within 6 weeks of receiving the COVID vaccine.
MD states, patient started with redness, warmth, and swelling to Left arm that night. Patient was seen by MD 5/11/2018 in clinic.
Swollen left knee where I had surgery back in 1992. I didn't have any problems until I took the shot. The knee became swollen. I went to urgent care, and I saw the doctor and he looked at the knee and did an x-ray. He came back and told me I had osteoarthritis in the knee. He prescribed meloxicam. The knee did go down, but I'm still suffering where the knee is still popping, and you can feel that. Feels like torn collagen in the knee. This is still going on now. It's been going on for a while off and on.
COVID 19 Treatment; COVID 19 Treatment; Interchange of vaccine products; This is a spontaneous report received from contactable reporter (Consumer or other non HCP) from product quality group.  A 50-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Oct2022 at 12:00 as dose 5 (booster), single (Lot number: LM9703) at the age of 51 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 16Mar2021 at 12:00 as dose 1, single (Lot number: EN6199), in left arm and on 13Apr2021 at 12:15 as dose 2, single (Lot number: ER8731), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 02Dec2021 at 09:45 as dose 3 (booster), single (Lot number: 18F2LA), in left arm and on 09Apr2022 at 09:30 as dose 4 (booster), single (Lot number: 065K21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hyperglycemia" (unspecified if ongoing); "beta thalassemia" (unspecified if ongoing); "Known allergies: Sulfa-based antibiotics" (unspecified if ongoing). Concomitant medication(s) included: DROSPIRENONE AND ETHINYL ESTRADIOL, start date: 01Jan2019, stop date: 08Jun2023. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 02Dec2021 at 09:45, outcome "unknown"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03Jun2023) Negative; (04Jun2023) Negative; (05Jun2023) Negative; (06Jun2023) Negative; (07Jun2023) Negative; (08Jun2023) Positive, notes: Tested positive twice. Therapeutic measures were taken as a result of vaccination failure and covid-19 with Paxlovid from 30May2023 to 03Jun2023.
Information has been received from a physician and a woman in a physician's office concerning a female who on 08-Aug-2006 at 10:50 am was vaccinated in the left thigh a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live (lot#653466/0466O).  Subsequently, 16 days after the vaccination, on 24-Aug-2006 at 09:00 am, the patient developed a generalized rash on her face, body and extremities.  It was unknown if medical attention was sought.  No outcome was reported.  No product quality complaint was involved.  Additional information has been requested.
tested positive; fever; chills; cough; This is a spontaneous report from a contactable physician. A 61-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported) on 28Jan2021 as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that after getting first dose the patient subsequently developed fever, chills and cough 1-2 days later (unknown date in 2021). They tested him for COVID-19 and he tested positive on 02Feb2021. Patient had high risk criteria for severe infection so they proceeded with giving him Bamlanivimab infusion on 03Feb2021. They were waiting 90 days now post infusion prior to vaccinating him. It was enquired that since how much time would have lapsed since getting his first vaccine, should patient start the series over or does he just need one more dose. Therapeutic measures were taken as a result of fever, chills, cough and tested. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
10-17-04 call from mother. Inj. site red, hard, swollen from shoulder to near elbow. Advised Tylenol, ice. 10-18 mother reports redness gone. Swelling improved. Not as hard. Able to move freely. Take notice: This involved the right arm only.
Severe chills, achy joints and muscles, fatigue, weak, headache, fever.  All those symptoms were severe for two days and then have had achy, fatigue, off and on sore throat, headaches ever since then up to current time of this report.
Information has been received from a a physician concerning a 4 year old male with no known drug allergies and no pertinent medical history who on 15-AUG-2005 was vaccinated SQ with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (WISTER RA 27/3) (lot# 649238/0029R). There was no concomitant medication. On 13-APR-2006 the patient developed mumps. On 13-Apr-2006, the patient was seen in the office with pain and swelling in his parotid gland. The patient's outcome was reported as recovering. Unspecified medial attention was sought. There was no product quality complaint involved. Additional information has been requested. This is an amended report. The reporter did not indicate other important medical event.
This report describes the occurrence of autism in a male child of unspecified age who was vaccinated with hep B vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received an injection of Engerix B "in or about 1999." He also received injections of hep B vaccine (Recombivax-HB) "in or about 1997," Hib-Titer "in or about 1999," diphtheria and tetanus toxoids and pertussis vaccine "in or about 1997," and Tri-Immunol "in or about 1999." The subject's attorney alleged that "As a result of the mercury in the thimerosal-containing vaccinations received during these developmental years, the subject now suffers and in the future will continue to suffer, fromt he toxic neurological effects of his mercury poisoning, including but not limited to autism." The autism and mercury poisoning in this report are considered medically serious (OMIC).  Follow up on 12/08/03: "The most recent info, received on 11/21/03, did not provide the outcomes of the alleged events.  The autism and mercury poisoning in this report are considered to be medically serious by GSK."
Had a swollen gland in my left jaw; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 10Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 12Mar2021, outcome "unknown", described as "Had a swollen gland in my left jaw". The event "had a swollen gland in my left jaw" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of lymphadenopathy. Additional information: The patient was prescribed six days supply of Medrol (treatment).   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Persistant crying post vax, possibly abdominal pain. Determined by provider that he had elevated erythrocyte sedimentation rate. No  further info available.
Report of muscle ache throughout entire body, extreme left arm pain; generalized joint pain & fatigue.  Note:  Had previous dose of Tdap 3/5/2009 (per mm registry).
contraindications POSITIVE HCG within 2 weeks of last Live Vaccines. MMR,  Varicella
2.5 months post first vaccine and has not received the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2.5 months post first vaccine and has not received the second dose) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Disability.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (2.5 months post first vaccine and has not received the second dose). On 29-Jul-2021, PRODUCT DOSE OMISSION ISSUE (2.5 months post first vaccine and has not received the second dose) had resolved.            Concomitant medication were not reported.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Aug-2021: Patient's relevant history updated.
Right after the shot (Maybe 2 days) I had huge swollen glands in my goin especially on the left side, then one week post vaccine I had a huge feeling of fullness in my uterus and started a period 2 weeks early. It was full of huge clots and was extremely heavy. My periods then happened on and off sporadically sometimes gushing (more than 4 tampons in an hour) often heavy clots and the feeling of fullness. Sometimes in between cycles it is just days of bright red spotting. This still continues. My last two period we're just 2 weeks apart and the clotting and gushing continue. I went to see the doctor after it continued a few months later wondering if it was something more. I believe my first appointment with Doctor was 6/7/21. She ordered multiple tests to include Hormone check, ultrasound, biopsies. I had to go through months of very unpleasant things to rule everything else out.   Nothing has changed with my situation or habits that would have caused this (married with child born 11 years ago)  There are also other things, that also events that have happened simultaneously.  I had a vaginal bacterial infection around the time if the first period post vaccine (cleared with treatment)
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 20-NOV-2017, the patient was vaccinated with an improperly stored dose of PROQUAD (recombinant Human albumin) (strength and route were unknown) (lot # N013863 and expiration date 31-OCT-2018) for prophylaxis. The sterile diluent (MERCK) was properly stored. No adverse event was reported. The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959.
severe outbreak of multiple coldsores, lips and inside nostrils, severe itching  and tenderness of scalp only at the back near hairline. these all occurred approximately 3 days after receiving 2nd shot.  These effects are in addition to the more common and expected ones, sore arm, mild flu symptoms, etc.  coldsore  outbreak was unusually painful, and  severe.  after discovering that many others experienced similar outbreaks after receiving vaccine I thought I should report it. I sought treatment through an online telehealth doctor and received prescription for valocyclovir.
pt recv vax 19NOV97 & 19NOV97 pt exp a fever of 103.1 & is not eating;
Reddened area 1" x 1" size at VARIVAX injection site right thigh.
2 days after Shingrix vaccine had a large red rash over injection site. It was very sore. She saw an Hospital ER provider on 7/3/19. Took Vitals - slightly elevated BP - all other vitals normal. The ER drew a circle around rash with marker. She was told to use warm or cold compress, take tylenol or ibuprofen as needed, and to return to ER or primary MD if got worse. As of 7/5/19 the rash is almost gone and the arm is still sore.
Arm Swollen and rash of about 4 1/2 inches in area. Painful and swollen. Pt was going to go see his regular Dr.
I had no reaction during my wait time. But 4 1/2 hrs. later, I had a large golf ball sized bump, redness hot, hives and very itchy with hives on vaccine site. That evening, I had fever of 100 & vomiting. Next morning, still had fever & vomiting & arm was still red, hot, itchy and now the size of a peach. I took Benadryl pill and my prednisone for next 2 days. Fever & vomiting went away.  Hives on arm have gone away with swelling, but now on day six there is still itching and redness, even after intravenous Benadryl at my infusion treatment.
This spontaneous report has been received from a nurse and refers to an unspecified number of children of unknown ages and genders. The patients' concurrent conditions, medical histories and drug reactions/allergies were not reported. On unknown dates, the patients were vaccinated with VARIVAX (doses routes of administration and frequencies were not reported) for prophylaxis. On unknown dates, the patients experienced varicella outbreaks at their school. At the reporting time, the outcome of varicella post vaccine was unknown. The reporter did not report a causal relationship between the event and the VARIVAX. This is one of several reports received from the same reporter (MARRS # 1712USA000896, 1712USA014554).; Sender's Comments: US-009507513-1712USA014554: US-009507513-1712USA000896:
On 3/5/01 at 16:00; started with a headache and pain in left arm. The next day, the left side of face was swollen X 1 day. Denies fever today and the arm is still painful and swollen. Also, she still has a headache. Will apply ice and take Tylenol.
Trouble with eyes focusing; Brain burning; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of VISION BLURRED (Trouble with eyes focusing) and HEADACHE (Brain burning) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Trouble with eyes focusing) and HEADACHE (Brain burning). At the time of the report, VISION BLURRED (Trouble with eyes focusing) and HEADACHE (Brain burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins); This spontaneous report with reference numbers 02197725 / 02197588 was received by partner on 05-JUL-2022 and forwarded on 06-JUL-2022 from a consumer.    The causal relationship between Vaxelis and the reported event "multiple doses of VAXELIS administered since temperature excursion" was assessed as not applicable due to the nature of the event.    Further information is expected.  FOLLOW-UP INFORMATION was received by a partner on 01-AUG-2022 and forwarded on 03-AUG-2022, from a HCP. The case is maintained as non-serious.  The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient.  Due to the nature of the event, the causality between the event "VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins)" and Vaxelis remained not applicable.  For reference purposes this case is linked to MCM-003725, MCM-003726, MCM-003729, MCM-003734, MCM-003735, MCM-003737, MCM-003738, MCM-003739, MCM-003740, MCM-003741, MCM-003742, MCM-003724, MCM-003744, MCM-003747, MCM-003749, MCM-003751, MCM-003752, MCM-003753, MCM-003757, MCM-003759, MCM-003760, MCM-003761, MCM-003763, MCM-003766, MCM-003767, MCM-003769, MCM-003770, and MCM-003772, due to same reporter.  No further information is expected.
Two weeks after receiving the vaccine, I had acute onset of severe vertigo lasting 10 days, followed by nine months and counting of debilitating positional (with movement) dizziness. Vestibular neuritis and migraine have both been suggested, but illness doesn't quite fit either diagnosis. I considered the flu vaccine connection when I found out that three other women on my dizzy health board developed the same condition (thought first to be neuritis and then possibly migraine vertigo) two to four weeks after receiving the flu vaccine. None of us had ever experienced any dizziness before in our lives.  09/17/2008 PCP records received. OV 12/3/2007 with c/o nausea and dizziness as well as nasal congestion. PE (+) for mild visible fluid lines in the ears, pale edematous tubinates with decreased patency on L.  Assess: Dizziness.  URI.  Returned 12/6/07 with increasing sx now descibed as debilitating. Feels dizzy with head movement. Increased anxiety 2' to vertigo. PE WNL. Assess:  Vertigo.  URI.  Anxiety.  Returned 5/20/08, now with 5 month hx of dizziness, lightheadedness, H/A, sleep problems, visual changes, weakness and fatigue. Has seen ENT and neuro- suspect vistibular neuritis or vestibular migraine. Depression 2' to sx. Assessment:  Acute sinusitis.  Dizziness. Place on abx with no improvement.
Initial case received from a health care professional on 17 August 2010. A 2-month old male patient received the following vaccinations on 09 August 2010: a first left anterior thigh injection of PENTACEL (lot number C3659AA); a first right anterior lower thigh injection of PREVNAR (Wyeth, lot number D3324); and a second right anterior upper thigh injection of RECOMBIVAX HB (Merck, lot number 0598X). The patient had no known allergies, no medical history, and was not ill at the time of vaccination. He was not taking any concomitant medications. Approximately 7 days post-vaccination (also reported as 17 August 2010), the patient began having intermittent, frequent jerking movements throughout the day. Movements began in the lower legs, and progressed to the right arm. Additionally, the patient's right arm was "fisted". He was seen by a physician, who described the movements as myoclonic jerks. At the time of the report, the events had not resolved.
Fatigue, fever, sweats, sever diarrhea, weakness.  General malaise for two and 1/2 days.
No symptoms being reported; patient inadvertently received an expired, unspecified dose in VAQTA immunization series; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/ allergies were not reported.  On 07-APR-2020 the patient was inadvertently vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) immunization series (lot # S002506, expiration date 04-APR-2020; dose, frequency and route were not reported) for prophylaxis (expired product administered). No symptoms were being reported.
She had softball size area of redness, swelling, itching, rash that lasted for 6 days. Fever of 102 degrees, nausea, upper respiratory coughing, sinus infection, flu.
Non-localized pain and soreness of injection site. I felt the normal pain and soreness for two days after injection at the site, but also along the side of my arm down through my elbow, up underneath my arm (armpit) and up along the side of my neck and top of my shoulder. This was my Booster dose and I did not have this problem with my first 2 doses. Also of note: my first 2 doses were Pfizer and this booster was Moderna.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Oct2022 as dose 4 (booster), single (Lot number: GH9703) at the age of 41 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Lot number: ER2613), in left arm, on 14Apr2021 as dose 2, single (Lot number: EW0158), in left arm and on 15Dec2021 as dose 3 (booster), single (Lot number: FJ876Z), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Bi-polar" (unspecified if ongoing); "Obesity" (unspecified if ongoing); "Low Vitamin D" (unspecified if ongoing); "3 episodes of pleurisy as an adult" (unspecified if ongoing), notes: 3 episodes of pleurisy as an adult. The patient's concomitant medications were not reported. Past drug history included: Bismuth oxychloride, reaction(s): "Known allergies: Bismuth Oxychloride".  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Positive, notes: positive test result two days after testing negative; Negative, notes: positive test result two days after testing negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.